cas 588687-37-0|| where to buy 5-cyclopropyl-4-methyl-4H-1,2,4-triazole-3-thiol

Nom du produit:5-cyclopropyl-4-methyl-4H-1,2,4-triazole-3-thiol

IUPAC Name:5-cyclopropyl-4-methyl-4H-1,2,4-triazole-3-thiol

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM114579-1g	in stock	Ʊǲɐ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Notes supplémentaires

Verification code*

refresh

: N° CAS:588687-37-0; Formule moléculaire:C6H9N3S; Point de fusion:-; Code SMILES:SC1=NN=C(C2CC2)N1C; Densité:

: Numéro de catalogue:CM114579; Poids moléculaire:155.22; Point d'ébullition:; N° Mdl:MFCD03421706; Stockage:

: Triazoles; Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.

: Cyclopropanes; Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.